These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21416113)

  • 21. Coagulation activation and expression of CD40 ligand on platelets upon in vitro lipopolysaccharide-challenge in patients with unstable angina.
    Kälsch T; Nguyen XD; Elmas E; Grebert N; Süselbeck T; Klüter H; Borggrefe M; Dempfle CE
    Int J Cardiol; 2006 Aug; 111(2):217-23. PubMed ID: 16182391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic hyper-reactivity of platelets resulting in enhanced monocyte recruitment in patients after ischaemic stroke.
    Lukasik M; Dworacki G; Michalak S; Kufel-Grabowska J; Watala C; Kozubski W
    Platelets; 2012; 23(2):132-42. PubMed ID: 21767237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of CD40 ligand and enhanced monocyte-platelet aggregate formation are associated with worse clinical outcome after ischaemic stroke.
    Lukasik M; Dworacki G; Kufel-Grabowska J; Watala C; Kozubski W
    Thromb Haemost; 2012 Feb; 107(2):346-55. PubMed ID: 22234746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of platelet function with clopidogrel is associated with a reduction of inflammation in patients with peripheral artery disease.
    Meyer A; Weithaeuser A; Steffens D; Bobbert P; Hassanein A; Ayral Y; Schultheiss HP; Rauch U
    Cardiovasc Revasc Med; 2016; 17(3):169-75. PubMed ID: 27157293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet activation in patients with peripheral vascular disease: reproducibility and comparability of platelet markers.
    Burdess A; Michelsen AE; Brosstad F; Fox KA; Newby DE; Nimmo AF
    Thromb Res; 2012 Jan; 129(1):50-5. PubMed ID: 21937092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationships among monocyte subsets, miRNAs and inflammatory cytokines in patients with acute myocardial infarction.
    Kazimierczyk E; Eljaszewicz A; Zembko P; Tarasiuk E; Rusak M; Kulczynska-Przybik A; Lukaszewicz-Zajac M; Kaminski K; Mroczko B; Szmitkowski M; Dabrowska M; Sobkowicz B; Moniuszko M; Tycinska A
    Pharmacol Rep; 2019 Feb; 71(1):73-81. PubMed ID: 30481637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of interleukin-6 during a 3-year follow-up in patients with acute ST-segment elevation myocardial infarction.
    Tan J; Hua Q; Li J; Fan Z
    Heart Vessels; 2009 Sep; 24(5):329-34. PubMed ID: 19784814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients.
    Danese S; Katz JA; Saibeni S; Papa A; Gasbarrini A; Vecchi M; Fiocchi C
    Gut; 2003 Oct; 52(10):1435-41. PubMed ID: 12970136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble CD40 ligand and interleukin-6 in the coronary circulation after acute myocardial infarction.
    Ohashi Y; Kawashima S; Mori T; Terashima M; Ichikawa S; Ejiri J; Awano K
    Int J Cardiol; 2006 Sep; 112(1):52-8. PubMed ID: 16376442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes of soluble CD40 ligand in the progression of acute myocardial infarction associate to endothelial nitric oxide synthase polymorphisms and vascular endothelial growth factor but not to platelet CD62P expression.
    Napoleão P; Monteiro Mdo C; Cabral LB; Criado MB; Ramos C; Selas M; Viegas-Crespo AM; Saldanha C; Carmo MM; Ferreira RC; Pinheiro T
    Transl Res; 2015 Dec; 166(6):650-9. PubMed ID: 26279254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspirin treatment influences platelet-related inflammatory biomarkers in healthy individuals but not in acute stroke patients.
    Lukasik M; Dworacki G; Michalak S; Kufel-Grabowska J; Golanski J; Watala C; Kozubski W
    Thromb Res; 2011 Nov; 128(5):e73-80. PubMed ID: 21788065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-dependent decrease of platelet activation and tissue factor by omega-3 polyunsaturated fatty acids in patients with advanced chronic heart failure.
    Moertl D; Berger R; Hammer A; Hutuleac R; Koppensteiner R; Kopp CW; Steiner S
    Thromb Haemost; 2011 Sep; 106(3):457-65. PubMed ID: 21800004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet-monocyte interaction in Mycobacterium tuberculosis infection.
    Kullaya V; van der Ven A; Mpagama S; Mmbaga BT; de Groot P; Kibiki G; de Mast Q
    Tuberculosis (Edinb); 2018 Jul; 111():86-93. PubMed ID: 30029921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet expression of CD40/CD40 ligand and its relation to inflammatory markers and adhesion molecules in patients with atrial fibrillation.
    Hammwöhner M; Ittenson A; Dierkes J; Bukowska A; Klein HU; Lendeckel U; Goette A
    Exp Biol Med (Maywood); 2007 Apr; 232(4):581-9. PubMed ID: 17392495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flow cytometric investigation of CD40-CD40 ligand system in preeclampsia and normal pregnancy.
    Lukanov TH; Bojinova SI; Popova VS; Emin AL; Veleva GL; Gecheva SP; Konova EI
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):306-12. PubMed ID: 19221099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma concentrations of soluble CD40 ligand in smokers with acute myocardial infarction: a pilot study.
    Kayrak M; Bacaksiz A; Ulgen MS; Vatankulu MA; Zengin K; Ayhan SS; Basaralı MK; Büyükbas S; Kiyici A
    Heart Vessels; 2011 Mar; 26(2):131-7. PubMed ID: 20978895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated inflammatory parameters are associated with lower platelet density in acute myocardial infarctions with ST-elevation.
    Järemo P; Hansson G; Nilsson O
    Thromb Res; 2000 Dec; 100(6):471-8. PubMed ID: 11152926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets.
    Garlichs CD; Eskafi S; Raaz D; Schmidt A; Ludwig J; Herrmann M; Klinghammer L; Daniel WG; Schmeisser A
    Heart; 2001 Dec; 86(6):649-55. PubMed ID: 11711459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective study of circulating soluble CD40 ligand concentrations and the incidence of cardiovascular disease in a nested prospective case-control study of older men and women.
    Jefferis BJ; Whincup PH; Welsh P; Wannamethee SG; Rumley A; Lawlor DA; Ebrahim S; Lowe GD
    J Thromb Haemost; 2011 Aug; 9(8):1452-9. PubMed ID: 21696538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers.
    Harding SA; Sarma J; Josephs DH; Cruden NL; Din JN; Twomey PJ; Fox KA; Newby DE
    Circulation; 2004 Apr; 109(16):1926-9. PubMed ID: 15078798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.